CapsoVision, Inc (CV) stock
CVNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30686% above fair value
$6.31−0.51 (-7.48%)
Close on Nov 19, 2026Market cap $315.80MP/E –Yield –
CapsoVision gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
CapsoVision's gross profit for the twelve months ending Jun 30, 2026 was $7.07M, up 5.6% year over year. For fiscal 2025 it was $7.17M, up 12.5% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.17M | +12.5% |
| FY2024 | Dec 31, 2024 | $6.38M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.87M | +3.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.33M | -11.0% |
| Q4 FY2025 | Dec 31, 2025 | $1.95M | +12.7% |
| Q3 FY2025 | Sep 30, 2025 | $1.91M | +15.5% |
| Q2 FY2025 | Jun 30, 2025 | $1.81M | +13.8% |
| Q1 FY2025 | Mar 31, 2025 | $1.49M | – |
| Q4 FY2024 | Dec 31, 2024 | $1.73M | – |
| Q3 FY2024 | Sep 30, 2024 | $1.66M | – |
| Q2 FY2024 | Jun 30, 2024 | $1.59M | – |
See a number that looks wrong?